When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Ichthyosis

Última revisão das evidências: 11 Sep 2026
Última atualização do tópico: 02 Jul 2026

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • scaling
  • skin changes at birth (in congenital ichthyosis)
  • onset in infancy (in ichthyosis vulgaris and X-linked ichthyosis)
  • adult onset (in acquired ichthyosis)
  • male sex
  • family history of ichthyosis
Detalhes completos

Outros fatores diagnósticos

  • history of atopy
  • history of associated systemic disease
  • history of associated infection
  • use of certain drugs
  • history of lymphoma or other malignancy
  • alopecia and ectropion in lamellar ichthyosis
  • cryptorchidism and corneal opacities
  • deafness, intellectual disability, limb defects, epilepsy, short stature
Detalhes completos

Fatores de risco

  • positive family history
  • parental consanguinity
  • use of certain drugs
  • history of lymphoma or other malignancy
  • history of associated systemic disease
  • history of HIV or leprosy
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • genetic testing
  • serum cholesterol sulfate
  • lipoprotein electrophoresis
  • steroid sulfatase activity
Detalhes completos

Investigações a serem consideradas

  • serum phytanic acid
  • imaging studies or other tests
Detalhes completos

Algoritmo de tratamento

CONTÍNUA

primary (genetic)

secondary (acquired)

Colaboradores

Autores

Fernanda Bellodi Schmidt, MD

Assistant Professor

Director of Pediatric Dermatology

Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery

University of Miami Miller School of Medicine

Miami, FL

Declarações

FBS is a principal investigator in an ichthyosis clinical trial sponsored by Timber Pharmaceuticals and is a principal investigator in an epidermolysis bullosa clinical trial sponsored by Anterogen Co. FBS lectures on various topics within the area of pediatric dermatology at the World Congress of Pediatric Dermatology, American Academy of Dermatology Annual Conference, American Academy of Dermatology Innovation Academy, and Masters of Pediatric Dermatology.

Elisa Secamilli, MD, PhD

​Assistant Professor

Director of Pediatric Dermatology

Division of Dermatology, Department of Internal Medicine

University of Campinas

Brazil

Declarações

ES has no competing interests.

Agradecimentos

Dr Fernanda Schmidt and Dr Elisa Secamilli would like to gratefully acknowledge Dr Timothy Patton, Dr Brittany Craiglow, and Dr Moise Levy, previous contributors to this topic.

Declarações

TP declared that he had no competing interests. BC declared that she is a member of the Foundation for Ichthyosis and Related Skin Types Advisory Board. BC is an author of a reference cited in this topic. MLL declared that he is the Drug Monitoring Committee Chair for Amgen, is on the advisory board for Arcutis, Pelthos, and Regeneron, has participated or will participate as an investigator for Castle Creek, Janssen, and Rheacell, and is a section editor and author for UpToDate. MLL also holds a patent for "Identification of Mutations in the Nemo Gene in Human Incontinentia Pigmenti" (US patent #6,824,972).

Revisores

David Cassarino, MD, PhD

Assistant Professor

Department of Pathology and Laboratory Medicine

University of California

Los Angeles, CA

Divulgaciones

DC declares that he has no competing interests.

Thierry Simonart, MD, PhD

Physician

Department of Dermatology

Erasme University Hospital

Brussels

Belgium

Divulgaciones

TS declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Akiyama M, Choate K, Hernández-Martín Á, et al. Nonsyndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy. Br J Dermatol. 2025 Sep 18;193(4):619-41.Texto completo  Resumen

Butala S, Mazereeuw-Hautier J, Paller AS. Ichthyosis: presentation and management. Curr Opin Pediatr. 2023 Aug 1;35(4):467-74. Resumen

Oji V, Tadini G, Akiyama M, et al. Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol. 2010 Oct;63(4):607-41. Resumen

Mazereeuw-Hautier J, Paller AS, Dreyfus I, et al. Management of congenital ichthyoses: guidelines of care: part one: 2024 update. Br J Dermatol. 2025 Jun 20;193(1):16-27. Resumen

Mazereeuw-Hautier J, Paller AS, O'Toole E, et al. Management of congenital ichthyoses: guidelines of care: part two: 2024 update. Br J Dermatol. 2025 Jun 20;193(1):28-43.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Ichthyosis images
  • Diferenciales

    • Asteatotic dermatitis (eczema craquele)
    • Atopic dermatitis
    • Psoriasis
    Más Diferenciales
  • Guías de práctica clínica

    • Management of congenital ichthyoses: guidelines of care: part one: 2024 update
    • Management of congenital ichthyoses: guidelines of care: part two: 2024 update
    Más Guías de práctica clínica
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad